InvestorsHub Logo

williamssc

05/10/18 8:21 PM

#227689 RE: Jhawker #227679

The bigger picture is we now know company is shopping for bigger office headquarters with room to expand it's own clinical development. Seems Leo plans to build a lab infrastructure and hire it's own scientists to develop B's full potential, K's potential so no company sell out. Leo plans to move into a larger pharma space makes sense to partner the one B-Om indication to get things rolling if P comes back great then even better but clearly Leo plans to stay in it.

DaubersUP

05/10/18 10:48 PM

#227741 RE: Jhawker #227679

First I am not reading into that like most....sorry. I am a BULL remember!

In early 2018, the Company approved steps to focus its efforts on clinical trials for its lead drug candidates. The Company’s office and laboratory needs have shifted from compound discovery to clinical development programs. The Company is now in the process of searching sites for its future headquarters.



To me that says nothing about expanding or going bigger. To me that says that they are done with labs and compound discovery. They have their 3 drugs. They are focused on BUSINESS DEVELOPMENT. I would think the headquarters would be small and business like... Maybe in Florida near Leo?

They have brought this company to a point where most Bio never go. 3 Drugs all in mid-late stage and very promising ....... No one ever gets this far ----- EVER without a deal and we have. Dilution - absolutely it occurred. Bad dilution - no. We added over 60 million in shares in 8 years but in those 8 years brought 3 drugs to mid-late stage. In a couple weeks we will have 3 drugs at the gates of phase 3! and all will be blockbusters.

Sorry, just had to give my 2cents. I don't read that quote as going huge and buying new space for a 100 person operation and labs. I read it as downsizing to a small affordable BUSINESS DEV Operation. All deals, managing and reporting to PARTNERS. Or maybe just a place to have 3rd parties send HUGE million dollar checks :)